Last month, in a speech before the Council on Foreign Relations in New York, GSK's CEO Andrew Witty pledged to expand his company's pool of patented compounds that others can use for free to try to develop medicines for neglected tropical diseases , and to hand control to a nonprofit group. Glaxo will give up to 60 outside scientists from universities and foundations access to a lab facility it calls the first-ever Open Lab, for developing new medicines for diseases plaguing poor countries. Witty also said Glaxo will give scientists around the globe free access to data on 13,500 drug compounds that show some effectiveness against malaria, one of the most devastating tropical diseases.
MoreThoughts?
2 comments:
www.wsws.org/articles/2003/may2003/glax-m28.shtml
Looks like GSK are doing their bit for third world countries by shutting the UK Tonbridge site by the end of the year, as announced today.
I hope to have some more details tomorrow.
Post a Comment